108 results
8-K
EX-99.1
BBLG
Bone Biologics Corp
6 Mar 24
Bone Biologics Announces Pricing of $2.0 Million Public Offering
4:20pm
of issuance. The closing of the offering is expected to occur on or about March 6, 2024, subject to the satisfaction of customary closing conditions.
H.C … to its plans, assumptions, expectations, beliefs and objectives with respect to the completion of the offering, the satisfaction of customary closing
8-K
EX-4.3
BBLG
Bone Biologics Corp
6 Mar 24
Bone Biologics Announces Pricing of $2.0 Million Public Offering
4:20pm
or otherwise) or the Holder’s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder
8-K
EX-10.1
BBLG
Bone Biologics Corp
6 Mar 24
Bone Biologics Announces Pricing of $2.0 Million Public Offering
4:20pm
to Section 2.2(a), and the Company and each Purchaser shall deliver the other items set forth in Section 2.2 deliverable at the Closing. Upon satisfaction … corporate purposes and shall not use such proceeds: (a) for the satisfaction of any portion of the Company’s debt (other than payment of trade payables
8-K
EX-4.1
BBLG
Bone Biologics Corp
6 Mar 24
Bone Biologics Announces Pricing of $2.0 Million Public Offering
4:20pm
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise
8-K
EX-4.2
BBLG
Bone Biologics Corp
6 Mar 24
Bone Biologics Announces Pricing of $2.0 Million Public Offering
4:20pm
firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated
424B4
tszu19
4 Mar 24
Prospectus supplement with pricing info
5:21pm
8-K
EX-4.2
8zaq54gwwixmw1k
20 Nov 23
Bone Biologics Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
7:46am